Publication: Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
Loading...
Identifiers
Date
2016
Authors
Boceta, J
De la Torre, A
Samper, D
Farto, M
Sánchez-de la Rosa, R
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
There is no unanimous consensus on the clinical features to define breakthrough cancer pain (BTcP). The current project aimed to investigate the opinion of a panel of experts on cancer pain on how to define, diagnose, assess, treat and monitor BTcP. A two-round Spanish multi-centre exploratory Delphi study was conducted with medical experts (n = 90) previously selected from Medical Oncology Services, Radiation Oncology, Palliative Care/Home Care Teams, and Pain Units. The study intended to seek experts' consensus and to define a set of recommendations for the management of BTcP. It was generally agreed that, definition of BTcP implies that baseline pain should be controlled (84 %), although not necessarily with opioids (only 30 %); there must be exacerbations (98.9 %); the duration of each episode should last The present Delphi study identified a set of recommendations to define, assess and monitor BTcP.
Description
MeSH Terms
Breakthrough Pain
Cancer Pain
Consensus
Delphi Technique
Pain Management
Cancer Pain
Consensus
Delphi Technique
Pain Management
DeCS Terms
CIE Terms
Keywords
Baseline cancer pain, Breakthrough cancer pain, Cancer, Consensus, Delphi, Management